US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 5.090
- +0.150+3.04%
Close Nov 22 16:00 ET
- 5.010
- -0.080-1.57%
Post 20:01 ET
296.79MMarket Cap-17551P/E (TTM)
5.160High4.900Low587.66KVolume4.930Open4.940Pre Close2.97MTurnover1.12%Turnover Ratio127.25P/E (Static)58.31MShares6.75052wk High0.55P/B267.84MFloat Cap3.46052wk Low--Dividend TTM52.62MShs Float33.440Historical High--Div YieldTTM5.26%Amplitude0.450Historical Low5.047Avg Price1Lot Size
Vanda Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -611.27%-14.58M | 47.59%-6.93M | -76.20%7.57M | -59.98%12.8M | -139.63%-3.73M | -115.97%-2.05M | -332.54%-13.22M | 686.04%31.8M | -50.19%31.98M | -64.61%9.42M |
| Net income from continuing operations | -3,986.13%-5.32M | -397.24%-4.52M | -227.49%-4.15M | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M |
| Operating gains losses | ---- | ---- | ---- | --655K | --0 | --0 | --0 | --655K | ---- | ---- |
| Depreciation and amortization | 239.14%1.97M | 226.91%1.97M | 231.94%2.22M | 10.14%3.01M | 74.66%1.16M | -14.45%580K | -12.75%602K | -4.56%670K | -3.80%2.73M | -6.09%663K |
| Deferred tax | -213.16%-3.09M | -184.81%-1.23M | -112.21%-246K | -213.81%-1.29M | -1,894.72%-7.48M | 248.56%2.73M | 177.93%1.46M | -54.40%2.01M | -83.25%1.13M | -68.24%417K |
| Other non cash items | -47.95%483K | -29.39%519K | -42.20%641K | 39.21%3.42M | -23.34%647K | 45.68%928K | 73.76%735K | 100.91%1.11M | 42.13%2.46M | 66.80%844K |
| Change In working capital | -42.22%-9.64M | 75.50%-4.61M | -68.34%6.98M | -112.30%-747K | 309.04%2.82M | -192.12%-6.78M | -16,615.79%-18.83M | 44,180.00%22.04M | 121.92%6.07M | -110.35%-1.35M |
| -Change in receivables | -119.18%-830K | 43.25%-5.16M | -129.06%-2.59M | 35.08%-707K | -18.79%-4.84M | 829.85%4.33M | -662.42%-9.1M | 354.83%8.9M | 55.89%-1.09M | -145.16%-4.07M |
| -Change in inventory | 61.37%-214K | 93.38%263K | -60.81%29K | 82.79%-771K | 62.21%-427K | 68.65%-554K | 133.75%136K | 106.28%74K | -100.58%-4.48M | -1,367.53%-1.13M |
| -Change in prepaid assets | 49.10%-3.66M | 53.94%-1.3M | -84.30%1.78M | 238.90%8.52M | 108.59%7.19M | -275.12%-7.19M | -751.36%-2.82M | 184.92%11.35M | -392.06%-6.14M | 104.57%3.45M |
| -Change in payables and accrued expense | -67.50%-469K | 196.76%3.14M | 110.80%1.17M | -193.14%-10.98M | 201.65%3.33M | -120.93%-280K | -1,160.13%-3.24M | -180.37%-10.79M | 287.93%11.79M | -250.32%-3.28M |
| -Change in other working capital | -45.05%-4.47M | 59.15%-1.55M | -47.33%6.59M | -46.67%3.19M | -166.21%-2.44M | -172.06%-3.08M | -253.35%-3.8M | 1,499.44%12.51M | 6.00%5.99M | 1,507.86%3.68M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -611.27%-14.58M | 47.59%-6.93M | -76.20%7.57M | -59.98%12.8M | -139.63%-3.73M | -115.97%-2.05M | -332.54%-13.22M | 686.04%31.8M | -50.19%31.98M | -64.61%9.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -65.87%12.06M | 92.00%-15.26M | -109.73%-18.22M | -124.15%-12.06M | -158.05%-43.78M | 262.22%35.33M | -1,208.21%-190.89M | 1,623.67%187.29M | 165.09%49.93M | 390.13%75.43M |
| Net PPE purchase and sale | -570.83%-161K | -96.36%-108K | 86.27%-7K | 43.59%-383K | 3.80%-253K | 83.78%-24K | 71.50%-55K | 32.00%-51K | -23.01%-679K | -96.27%-263K |
| Net investment purchase and sale | -65.44%12.22M | 92.86%-13.63M | -108.28%-15.51M | 75.86%88.99M | -24.52%57.14M | 263.44%35.35M | -1,225.36%-190.84M | 1,612.32%187.35M | 166.46%50.6M | 392.65%75.69M |
| Net other investing changes | --0 | ---1.52M | ---2.71M | ---100.67M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -65.87%12.06M | 92.00%-15.26M | -109.73%-18.22M | -124.15%-12.06M | -158.05%-43.78M | 262.22%35.33M | -1,208.21%-190.89M | 1,623.67%187.29M | 165.09%49.93M | 390.13%75.43M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -79.32%734K | -41.88%605K | |||||||
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -79.32%734K | -41.88%605K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -79.32%734K | -41.88%605K |
| Net cash flow | ||||||||||
| Beginning cash position | -31.28%103.42M | -64.58%125.63M | 0.58%136.29M | 157.65%135.5M | 268.30%183.66M | 156.21%150.5M | 425.82%354.64M | 157.65%135.5M | -14.64%52.59M | -2.30%49.87M |
| Current changes in cash | -107.58%-2.52M | 89.13%-22.19M | -104.86%-10.65M | -99.10%745K | -155.61%-47.52M | 472.39%33.28M | -2,224.23%-204.11M | 1,369.27%219.1M | 1,025.25%82.64M | 5,078.73%85.45M |
| Effect of exchange rate changes | 155.74%68K | 42.31%-15K | -131.11%-14K | -82.26%47K | -18.03%150K | -303.33%-122K | -132.91%-26K | 178.95%45K | 391.21%265K | 281.19%183K |
| End cash Position | -45.02%100.97M | -31.28%103.42M | -64.58%125.63M | 0.58%136.29M | 0.58%136.29M | 268.30%183.66M | 156.21%150.5M | 425.82%354.64M | 157.65%135.5M | 157.65%135.5M |
| Free cash flow | -610.80%-14.74M | 47.00%-7.04M | -76.18%7.56M | -60.33%12.42M | -143.54%-3.99M | -116.34%-2.07M | -341.72%-13.28M | 699.60%31.75M | -50.83%31.31M | -65.43%9.15M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data